BioCryst Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:BCRX) : vimarsana.com

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) was the target of unusually large options trading on Monday. Stock investors acquired 2,478 call options on the stock. This is an increase of approximately 59% compared to the average volume of 1,554 call options. Analyst Ratings Changes Separately, Needham & Company LLC reiterated a “buy” rating […]

Related Keywords

Los Angeles , California , United States , China , , Los Angeles Capital Management , Biocryst Pharmaceuticals , Counterweight Ventures , Nasdaq , Needham Company , Vanguard Group Inc , China Universal Asset Management Co , Institutional Trading Of Biocryst Pharmaceuticals , News Ratings For Biocryst Pharmaceuticals Daily , Biocryst Pharmaceuticals Stock , Biocryst Pharmaceuticals Company Profile , Mirae Asset Global Investments Co , Biocryst Pharmaceuticals Inc , Get Free Report , Cryst Pharmaceuticals , Asset Global Investments , Universal Asset Management , Angeles Capital Management , Biocryst Pharmaceuticals Daily , Nasdaq Bcrx , Bcrx , Medical , 09058v10 , Stocks , Options , Put , Call ,